ACM
RGEN icon

Aster Capital Management’s Repligen RGEN Stock Holding History

Aster Capital Management’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,452
Closed -$1.19M – 1488
2025
Q1 		$1.19M Buy
+7,452
New +$1.15M 0.22% 124

Other funds holding RGEN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Aster Capital Management's RGEN Position: Q2 2025 in Review

Aster Capital Management sold out of Repligen (RGEN) in Q2 2025, closing a stake of 7,452 shares — an estimated $1.19M sold.

Aster Capital Management first reported a position in RGEN in Q1 2025 and held it in 1 quarter. The position peaked at $1.19M in Q1 2025. 444 funds tracked by Wall St. Rank hold RGEN as of Q2 2025.

  • Aster Capital Management reported no remaining Repligen position as of Q2 2025 after selling out during the quarter.
  • Aster Capital Management sold 7,452 Repligen shares in Q2 2025, an estimated $1.19M.
  • Aster Capital Management first reported a position in Repligen in Q1 2025 and held it in 1 quarter.
  • Aster Capital Management's Repligen position peaked at $1.19M in Q1 2025.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q2 2025.

Based on Aster Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.